SIMP Activators
SIMP activators encompass a diverse range of chemical compounds that indirectly enhance the functional activity of SIMP by modulating various cellular signaling pathways. The first group of activators targets cyclic nucleotide pathways: Forskolin, by raising cAMP levels, facilitates PKA activation, which may phosphorylate SIMP, thus enhancing its activity. SNAP operates similarly by increasing cGMP levels, which activates PKG and could lead to SIMP activation. Sildenafil sustains this effect by inhibiting cGMP breakdown. In contrast, PMA and A23187 modulate protein kinase C and calcium-dependent kinases, respectively, both of which could phosphorylate and activate SIMP through different mechanisms.
The second paragraph focuses on activators that modulate specific kinase pathways or cellular conditions that indirectly influence SIMP activity. EGCG, by inhibiting competitive kinases, shifts cellular signaling balance towards pathways that could enhance SIMP activity. LY294002 and U0126 inhibit PI3K and MEK1/2, respectively, leading to the alteration of AKT signaling and the reduction of competitive MEK signaling, which may result in the enhancement of SIMP function. SB203580 takes a similar approach by inhibiting p38 MAPK, which could also shift signaling towards SIMP activation. In the realm of neural signaling, Tetrodotoxin alters neuronal excitability, which could indirectly modulate SIMP activity within neural tissues. Lastly, Resveratrol activates SIRT1, potentially leading to the deacetylation and activation of SIMP or associated regulatory proteins. Collectively, these chemical compounds employ multifaceted mechanisms to enhance the functional activity of SIMP.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, resulting in increased levels of cyclic AMP (cAMP) within the cell. Elevated cAMP can lead to the activation of protein kinase A (PKA), which may phosphorylate SIMP or associated proteins, enhancing SIMP activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC can phosphorylate target proteins directly associated with SIMP, leading to its functional activation through post-translational modifications. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. Elevated calcium levels could activate calmodulin-dependent kinases, which might then phosphorylate SIMP or proteins in its pathway, resulting in enhanced SIMP function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain protein kinases. By inhibiting competitive pathways, EGCG may shift the balance of cellular signaling towards pathways that enhance the function of SIMP. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can lead to alterations in downstream AKT signaling. Inhibition of AKT can modify the phosphorylation state of proteins in pathways associated with SIMP, potentially leading to its enhanced activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore, similar to Ionomycin, and acts to increase intracellular calcium concentration. This can activate calcium-dependent protein kinases that might phosphorylate SIMP or its associated proteins, enhancing its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which may shift cellular signaling towards pathways that enhance SIMP activity by reducing competitive signaling through the p38 MAPK pathway. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is known to activate SIRT1, a NAD+-dependent deacetylase. Activation of SIRT1 can lead to the deacetylation of proteins that interact with or regulate SIMP, thus potentially enhancing SIMP's functional activity. | ||||||